The Michigan Biomedical Venture Fund (MBVF) invests in biomedical startup companies with U-M licensed IP in the domain of therapeutics, devices, diagnostics, or health IT. The MBVF is a collaborative effort between the U-M Medical School’s Fast Forward Medical Innovation (FFMI) program and the U-M College of Engineering’s Center for Entrepreneurship (CFE).
With a $3 million gift from the Monroe-Brown Foundation, the MBVF awards $50,000-$300,000 to biomedical startup companies. The Fund serves to drive the university’s world-class leadership by creating a critical pipeline between research and the biomedical innovation life cycle.
As part of the Michigan Biomedical Venture Fund, Matt is responsible for analyzing incoming deal prospects, assisting in managing the growing portfolio of investments, building the fund's network, and assisting the CFE teams as needed. Matt comes from the UM Coulter Translational Research Partnership Program, where he served as Project Manager. While there, Matt assisted in the development and commercialization of several new medical device product concepts. Matt also has experience working in the medical device and in-vitro diagnostics industry in various roles for Medtronic, Boston Scientific, and others. He received an M.S. in Medicinal Chemistry from the University of Michigan.
Matthew was BECO’s first ever speaker, he helped to answer many difficult questions such as what’s something that can prevent the success of a startup or project that most people don’t think about, what do you look for in a potential startup, and can you talk a little about what you do as an analyst?
Matthew helped to illustrate what life is like in the VC industry to help club members understand if this career path is a good fit for them.